Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical composition for treating myocarditis and application of pharmaceutical composition

A composition and a technique for myocarditis, which are applied in the directions of drug combinations, medical preparations containing active ingredients, pharmaceutical formulas, etc., can solve the problems of large toxic and side effects, no disease research, and insignificant overall effects.

Inactive Publication Date: 2015-03-25
江志鑫
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Children with viral myocarditis often use western medicine antibiotics, such as oral ribavirin, intravenous inosine, potassium magnesium aspartate, vitamin C, etc. The overall effect is not obvious, the cure rate is low, and the side effects are large
However, in terms of traditional Chinese medicine treatment in our country, there has been no drug with very definite curative effect. Most of the Chinese patent medicines are based on empirical prescriptions with addition and subtraction of medicinal flavors, combined with Western medicine treatment measures
Neither in-depth research on diseases nor development of new traditional Chinese medicines with unique curative effects

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0067] A kind of pharmaceutical composition for the treatment of myocarditis of the present invention, take following Chinese medicine crude drug: Radix Notoginseng 13 grams, Radix Paeoniae Rubra 10 grams, Baiziren 3 grams, Forsythia 7 grams, Radix Astragali 19 grams, coriander 25 grams, willow branch 36 grams 18 grams of poplar branch, 30 grams of peach branch, 45 grams of reed root, 16 grams of herb, 2 grams of rush, 7 grams of safflower, 35 grams of Chuanxiong, 30 grams of curcuma, 16 grams of Radix Radix, 13 grams of turmeric, 25 grams of Scallion , 5 grams of cinnamon sticks, 15 grams of heterophylla, 30 grams of melon wilt, 16 grams of light bamboo leaves, 23 grams of Araceae, 3 grams of roasted licorice, 9 grams of Albizia juniper, 7 grams of schisandra, 12 grams of salvia, 15 grams of cohosh, white 10 grams of Weiwei, 15 grams of Cistanche, 17 grams of Mildew Spatholobus, 15 grams of purslane, and 8 grams of Qingzizi.

[0068] The preparation method of the pharmaceutic...

Embodiment 2

[0074] A kind of pharmaceutical composition for the treatment of myocarditis of the present invention, get following Chinese medicine crude drug: Panax notoginseng 11 grams, Radix Paeoniae Rubra 12 grams, Baiziren 3.5 grams, Forsythia 8 grams, Radix Astragali 17 grams, coriander 22 grams, willow branch 32 grams 16 grams of poplar branch, 30 grams of peach branch, 40 grams of reed root, 12 grams of herb, 3 grams of rush, 5 grams of safflower, 35 grams of Chuanxiong, 33 grams of curcuma, 16 grams of Radix Radix, 13 grams of turmeric, 20 grams of Scallion , 5 grams of cinnamon sticks, 13 grams of heterophylla, 31 grams of melon wilt, 16 grams of light bamboo leaves, 23 grams of Araceae, 3 grams of roasted licorice, 3 grams of acacia bark, 5 grams of schisandra, 10 grams of salvia miltiorrhiza, 15 grams of cohosh, white 10 grams of Weiwei, 12 grams of Cistanche, 41 grams of Millet Spatholobus, 40 grams of purslane, and 32 grams of Qingzizi.

[0075] The preparation method of the p...

Embodiment 3

[0081] A kind of pharmaceutical composition for the treatment of myocarditis of the present invention, get following Chinese medicine crude drug: Panax notoginseng 9 grams, Radix Paeoniae Rubra 10 grams, Bai Ziren 4.5 grams, Forsythia 8.5 grams, Radix Astragali 15 grams, coriander 20 grams, willow branch 28 grams 11 grams of poplar branches, 30 grams of peach branches, 40 grams of reed root, 11 grams of herb, 3.5 grams of rushes, 5.5 grams of safflower, 35 grams of Chuanxiong, 35 grams of curcuma, 12 grams of Radix Ophiopogon, 11 grams of turmeric, and 20 grams of scallion , 5 grams of cinnamon sticks, 11 grams of heterophylla, 34 grams of melon wilt, 18 grams of light bamboo leaves, 23 grams of Araceae, 3.5 grams of roasted licorice, 3 grams of acacia bark, 5 grams of schisandra, 10 grams of salvia miltiorrhiza, 15 grams of cohosh, white 10 grams of Weiwei, 12 grams of Cistanche, 25 grams of Mildew Spatholobus, 25 grams of purslane, and 28 grams of Qingzizi.

[0082] The prep...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a pharmaceutical composition for treating myocarditis. The pharmaceutical composition is mainly prepared from the following raw materials: pseudo-ginseng, red peony root, semen boitae, fructus forsythiae, astragalus membranaceus, coriander, willow branch, david poplar twig, peach juvenile branchlet, rhizoma phragmitis, rhizoma atractylodis, junci medulla, flowers carthami, ligusticum wallichii, curcuma zedoary, radix ophiopogonis, radix curcumae, allium macrostemon, cassia twig, radix pseudostellariae, trichosanthes kirilowii, lophatherum gracile, rhizoma arisaematis, honey-fried licorice root, cortex albiziae, schisandra chinensis, salviae miltiorrhizae, rhiizoma cimicifugae foetidae, blackend swallowwort root, herba cistanche, suberect spatholobus stem, herba portulacae and seed of feather cockscomb. The pharmaceutical composition has the efficacies of tonifying qi, nourishing vigor, strengthening body resistance to dispel pathogenic factors, nourishing the heart and dredging veins, is capable of regulating the immune function in two ways, is effectively controlling various myocarditis symptoms, protecting the cardiac muscle and promoting myocardial function recovery, and is significant in curative effect.

Description

technical field [0001] The invention relates to a pharmaceutical composition, in particular to a pharmaceutical composition for treating myocarditis and its application. Background technique [0002] Myocarditis refers to localized or diffuse acute, subacute or chronic inflammatory lesions in the myocardium. The relative incidence of viral myocarditis has been increasing in recent years. The severity of the disease varies greatly, and the manifestations vary greatly. Infants and young children are usually more serious, and adults are mostly milder. The milder patients may have no obvious symptoms, and the severer patients may be complicated by severe arrhythmia, cardiac insufficiency or even sudden death. Prodromal symptoms of myocarditis in the acute or subacute phase. Patients may have fever, fatigue, sweating, palpitation, shortness of breath, and precordial pain. Examination showed premature contraction, conduction block and other arrhythmias, increased aspartate amino...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/9066A61P9/00
CPCA61K36/258A61K9/0095A61K9/1623A61K36/14A61K36/185A61K36/21A61K36/23A61K36/236A61K36/27A61K36/284A61K36/286A61K36/36A61K36/428A61K36/48A61K36/481A61K36/484A61K36/486A61K36/537A61K36/54A61K36/57A61K36/634A61K36/64A61K36/71A61K36/736A61K36/76A61K36/79A61K36/88A61K36/8884A61K36/8962A61K36/8968A61K36/899A61K36/9066A61K2236/15A61K2236/331A61K2236/39A61K2236/51A61K2236/53A61K2236/55A61K2300/00
Inventor 不公告发明人
Owner 江志鑫
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products